2022
-
Renowned Medical Oncologist, Investigator to Take Reins at IASLC in March
Longtime member Karen Kelly, MD, is set to become the new chief executive officer of the International Association for the Study of Lung Cancer. This March, Dr. Kelly, an internationally […]
-
LungMATCH Program Models Best Practices for Empowering Patients
For people diagnosed with lung cancer and their families, understanding the illness and its treatments enough to participate in healthcare decisions can be challenging. Patients may not understand the benefits […]
-
The Art and Science of Patient–Doctor Communication
When facing a grave illness, especially for the first time, many people are worried, frightened, and overwhelmed. They may have difficulty focusing their attention on daily tasks and experience skewed […]
-
Keynote Addresses Lessons from SCLC Mouse Models
Experimental model systems are an indispensable part of research into SCLC. At the International Association for the Study of Lung Cancer’s 2021 Hot Topic Meeting: Small Cell Lung Cancer, keynote […]
-
CDX Models Help Bring Personalized Treatment for SCLC a Step Closer
A growing body of research in SCLC has revealed greater phenotypic heterogeneity within this disease than previously realized. Circulating-tumor-cell-derived explant models (CDX) are providing researchers with a resource to facilitate […]
-
Preconditioning Program Shortens Postsurgical Hospital Stay for People with Lung Cancer
Reducing complications after lung cancer surgery could generate positive changes across healthcare, from better outcomes and quality of life to cost savings. Even a small decrease in incidence of postoperative […]
-
Enhancing Understanding of Testing Applications, Best Practices: A Q&A with Dr. Lynette M. Sholl
Lynette M. Sholl, MD, Chief of Thoracic Pathology and Associate Director of the Center for Advanced Molecular Diagnostics at Brigham and Women’s Hospital and Associate Professor at Harvard Medical School, […]
View ILCN Archives
Provider Resources